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The relevance of blood flow for the outcome of radiation treat-
ments was already described by Schwartz in 1909. He noticed that
skin reactions were less severe when the radium applicator was
firmly pressed to the skin. It was Cramer in 1935 who gave the
first suggestion of an ‘oxygen effect’. He found that mouse
mammary tumours with a well developed stroma and vascular
network were more radiosensitive than tumours with a more deli-
cate stromal component. He suggested that the radiosensitive
tumours had a better blood supply and, consequently, were better
oxygenated. Later, Gray et al (1953) established the importance of
tumour oxygenation for radiotherapy.
The tumour micro-environment is a key factor in tumour
biology and has great impact on clinical radiotherapy as well as
other cancer treatments. Single parameters such as polarographic
pO2 measurements and microvascular density have been demon-
strated to be prognostic indicators in a variety of tumour types,
including carcinomas of the head and neck (Gatenby et al, 1987;
Dray et al, 1995; Zätterström et al, 1995; Jenssen et al, 1996;
Nordsmark et al, 1996; Brizel et al, 1997). However, considering
the complexity of the micro-environmental system, it is unlikely
that a single parameter can reliably predict treatment outcome on
an individual basis. Multiple parameter analysis will be necessary
to acquire a better understanding of the tumour micro-environment
and to obtain a ‘predictive profile’ which can guide the clinician in
the selection of patients for new treatment strategies.
A computerized image analysis system for multi-parameter
analysis has been developed in our institute (Rijken et al, 1995).
The method involves computer controlled microscopic scanning
of immunohistochemically stained tissue sections. It allows
quantitative and simultaneous analysis of vascular parameters,
oxygenation status and proliferation parameters. We have recently
published our experience with this method in xenografted human
tumours (Bussink et al, 1998, 1999).
We now apply this method also to tumour biopsies from patients
with squamous cell carcinomas of the head and neck. Before a
biopsy was taken, the patients were injected with Hypoxyprobe-1
(pimonidazole hydrochloride) as a hypoxia marker. Pimonidazole
can easily be dissolved in saline, has a low toxicity, and an effi-
cient tumour uptake. So far pimonidazole has proven to be an
effective hypoxia marker for human tumours of the cervix and
head and neck (Kennedy et al, 1997; Raleigh et al, 1998; Varia et
al, 1998). In the present study we report the results of the analysis
of biopsy material from 21 patients with squamous cell carcinoma
of the head and neck.
MATERIALS AND METHODS
Patients
Patients with primary laryngeal, oropharyngeal (stage III–IV) or
hypopharyngeal (stage II–IV) squamous cell carcinomas were
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for our ongoing phase II ARCON-study (Accelerated Radio-
therapy with Carbogen and Nicotinamide) (Kaanders et al, 1995).
Inclusion criteria were: age over 18 years, WHO performance
status of 0–2, no severe heart or lung disease, no severe liver or
kidney dysfunction, no severe stridor, no distant metastases, and
written informed consent. In the period from May 1998 to
December 1998, 21 patients were included. Approval from the
local ethics committee was obtained.
Markers of hypoxia and proliferation
As hypoxia marker we used pimonidazole hydrochloride
(Hypoxyprobe-1, Natural Pharmacia International Inc).
Pimonidazole is a bioreductive chemical probe with an immuno-
recognizable side chain. The addition of the first electron in bio-
reductive activation is reversibly inhibited by oxygen with a half
maximal pO2 of inhibition of 3 mmHg and almost complete inhibi-
tion at about 10 mmHg (Raleigh et al, 1999). Pimonidazole 
(0.5 g/m2) was dissolved in 100 cc NaCl 0.9% and was adminis-
tered intravenously over 20 minutes, two hours before biopsy
(range 1 h 35 min–4 h 05 min, median 1 h 59 min). A maximum
dose of one gram was given to patients with a body surface >2 m2.
After biopsy the tissue was directly frozen in liquid nitrogen.
Sections of 5 µ m were cut and mounted on poly-L-lysine coated
slides and stored at –80° C until staining.
Immunohistochemical staining
Prior to the staining procedure, sections were fixed in acetone of
4° C for 10 min. Then the sections were rehydrated in phosphate
buffered saline (PBS). Next, sections were incubated overnight at
4° C with both anti-pimonidazole (rabbit polyclonal) (Azuma et al,
1997) diluted 1:200 in PBS and PAL-E diluted 1:5 in PBS
(Department of Pathology, University Hospital Nijmegen, The
Netherlands). The monoclonal antibody PAL-E is a marker for
human endothelium, especially useful in frozen tissue sections
(Schlingemann et al, 1985). After rinsing three times in PBS the
staining procedure was followed by a pooled incubation for 1 h at
room temperature with fluorescein isothiocyanate (FITC)-conju-
gated donkey anti-rabbit antibody (Jackson Immuno Research
Laboratories, West Grove, PA, USA) 1:100 in PBS for the hypoxia
signal, combined with tetramethyl rhodamine isothiocyanate
(TRITC)-conjugated goat anti-mouse antibody (Jackson Immuno
Research Laboratories, West Grove, PA, USA) diluted 1:100 in
PBS to visualise the vessels. After rinsing in PBS for three times
the sections had another pooled incubation for 1 h with the same
FITC-conjugated antibody, but now combined with TRITC-
conjugated donkey anti-goat antibody (Jackson Immuno Research
Laboratories) diluted 1:100 in PBS to amplify the blood vessel
signal. Slides were then rinsed and mounted in PBS for scanning
of the hypoxia and vessel signals.
Scanning of tumour sections and image processing
For quantitative analysis, the slides were scanned by a computer-
ized image processing system using a high-resolution intensified
solid-state video camera on a fluorescence microscope (Zeiss
Axioskop). The fluorescence signals were recorded by the camera
and subsequently digitized to a binary image on a Macintosh
computer. For the vessels (TRITC-signal, 510–560 nm excitation)
a 590 nm emission filter was used and for hypoxia (FITC-signal,
450–490 nm excitation) a 520 nm emission filter was used. In
order to move a tissue section automatically a motorized scanning
stage, coupled to a stage controller, was interfaced with the
computer. Each tumour section was scanned two times at 100×
magnification. In the first scan only the vascular structures were
detected, in the second scan the hypoxic marker was detected.
Each scan consisted of 16, 25 or 36 fields (4× 4, 5× 5 or 6× 6, field
size 1.22 mm2) depending on the size of the biopsy. Processing all
fields of one scanning procedure resulted in a composite binary
image. After the scanning procedure the two composite binary
images, one showing vascular structures and the other showing
hypoxic areas, were superimposed. A detailed description of the
scanning method has been given by Rijken et al (1995). With the
use of a haematoxylin-eosin staining of a consecutive section the
tumour area was delineated. This area was used as a mask in
further image analysis excluding non-tumour tissue and large
necrotic areas from the analysis. Necrosis can produce an 
aspecific  red stain in the fluorescent images. It is therefore impor-
tant that these areas be excluded such that they do not disturb the
analysis of vascular parameters. Small necrotic areas were not
excluded because this could cause loss of information of the
directly surrounding viable tissue. The delineation of the tumour
area was supervised by a pathologist (PCM de Wilde).
Analysis of hypoxic and vascular parameters
The vascular density was calculated as the number of vascular
structures per mm2. The relative vascular volume was defined as
the PAL-E positive surface divided by the total tumour surface.
The hypoxic fraction was defined as the pimonidazole positive
surface divided by the total tumour surface. These parameters
were calculated for the complete tumour surface, but also in
arbitrary subareas of 0.3 mm2 for analysis of the intra-tumour
variability.
In order to quantitate the distribution of hypoxia in relation to
the vasculature, zones were chosen arbitrarily at increasing
distance from the surface of the nearest vessel (0–50 µ m, 50–
100 µ m, 100–150 µ m, 150–200 µ m, 200–250 µ m, and >250 µ m).
The hypoxic fraction in a zone was calculated as the pimonida-
zole-stained surface in a zone divided by the tumour surface in that
zone.
Statistics
Mean values were compared by the student-t-test. Correlations
between various parameters were tested by linear least-squares
regression analysis. The statistical analyses were done on a
Macintosh computer using Statistica 4.0 software.
RESULTS
Patients
Twenty-three patients entered the study. Two biopsies were not
included in the analysis, one biopsy contained no tumour tissue
and one patient had a mucoepidermoid carcinoma. Thus biopsies
from 21 patients with confirmed squamous cell carcinoma were
the subject of this study. The median age of the patients was 58
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were localized in the oropharynx (2), in the larynx (9) and in the
hypopharynx (9). One patient suffered from two primary tumours,
an oropharyngeal and a hypopharyngeal tumour which were both
biopsied. Thirteen tumours were moderately differentiated and
nine were poorly differentiated. Classification of the tumours
according to the TNM staging system (as defined by the UICC,
1997) is shown in Table 1. None of the patients had any adverse
reaction to the pimonidazole administration.
Hypoxia and vessel staining
The hypoxic staining gave a reproducible and bright green fluores-
cent signal in all tissue sections. At increasing distance from the
vessels an increasing intensity of the hypoxic staining was found.
There was no or very little background staining (Figure 1). At the
edges of some tumour sections we observed a strong staining. This
so called ‘edge-effect’ was sometimes substantial and, if included
in the analysis, could influence the outcome significantly. Three
different causative phenomena were identified. First, freezing arte-
facts occur sometimes at the tissue edges which are caused by the
formation of ice crystals with subsequent tissue damage. These
freezing artefacts are known to give non-specific staining with
immunohistochemical techniques. Secondly, the edges of tissue
sections can become pleated while being cut, which enhances the
background staining. The third reason is the presence of normal
epithelium covering the surface of a biopsy. The differentiated
squamous layers can demonstrate considerable hypoxia. The latter
is obviously not an artefact but was excluded from the analysis as
non-tumour tissue. In the majority of the biopsies no or very little
normal epithelium was identified.
The red fluorescent vessel staining gave a strong signal in all
tumours with hardly any background staining. Some aspecific
staining was observed in areas of necrosis, which also can contain
remnants of blood vessels (Figure 1).
Staining patterns
Based on the vascular architecture and the pattern of hypoxic
staining we have tried to categorize the tumours into three groups.
Category A (n = 8) showed increasing amounts of hypoxia with
increasing distance from the vessels and large areas of hypoxia at
distances greater than 200 µ m. They had almost no hypoxia close
to the vessels (Fig. 2A). Category B (n = 4) tumours had a typical
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Table 1 TNM-classification of the 22 biopsied tumours
N0 N1 N2 N3 Total
T1 – 1 1 – 2
T2 1 1 3a 27
T3 2 1 5a –8
T4 – 2 3 – 5
Total 3 5 12 2 22
a Biopsies from one patient with two primary tumours
Figure 1 Fluorescence microscopic image of a tumour section (200 × magnification) after staining for hypoxia with pimonidazole (green) and vessels with
PAL-E (red). Typical tumour cords can be recognized with well oxygenated areas directly adjacent to vessels and hypoxia at greater distance. At even greater
distances there is necrosis (white arrow, confirmed in H&E stain)Vasculature and hypoxia in human head and neck cancer 677
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Figure 2 Composite binary images of four different tumours; sccNij50 (A), sccNij70 (B), sccNij49 (C) and sccNij69 (D) showing hypoxia (green) and vessels
(red). The tumours represent examples of different hypoxic patterns. Large necrotic areas have been excluded from these binary images. Only in tumour
sccNij70 there were areas of necrosis that were too small to be excluded (arrows)band-like pattern of hypoxia at shorter distances from the vessels
(between 50 and 200 µ m) (Fig. 2B). In this category of tumours
we found small areas of necrosis at distances >150–200 µ m. This
was confirmed in the haematoxylin-eosin staining but these 
areas were too small to be excluded from the analysis. Category C
demonstrated a more diffuse hypoxic pattern with significant
amounts of hypoxia in the zones closest to the vessels. The relation
to the vasculature was less obvious in this category (n = 4) (Fig.
2C). Even tumours with similar hypoxic fractions could vary in
their hypoxic patterns. Six tumours had small hypoxic fractions of
less than 5% and, therefore, could not be properly classified (Fig.
2D).
Quantitative analysis
Vascular parameters
The vascular density (VD) of the 22 tumours ranged from 11 mm–2
to 67 mm–2 with a median value of 42 mm–2. The vascular density
was also calculated in arbitrary subareas of 0.3 mm2. The highest
values of these subareas were a factor of 1.5 to 6 higher than the
overall values of the various tumours.
The relative vascular volume varied from 1.9% to 9.0%, with a
median of 3.8%. There was no correlation between the vascular
parameters and tumour site, T- and N-stage or histological grade.
Hypoxia
Figure 3 presents the hypoxic fractions of the tumours as a cumu-
lative plot. The lowest and highest values were 0.02 and 0.29,
respectively, with a median of 0.09. There was an indication that
pharyngeal tumours had a higher hypoxic fraction (median 0.10)
as compared to the larynx tumours (median 0.05). However, these
differences were not statistically significant (P = 0.21, t-test).
There was also no correlation between T- and N-stage or histo-
logical grade and the hypoxic fraction.
Hypoxic fractions were also calculated for the subareas in each
tumour and cumulative plots were constructed. Figure 4 shows
these plots for the three tumours of which the corresponding
images are shown in Figure 2. The steepest curve with the lowest
median value (=0.03) corresponds with the tumour that demon-
strates hypoxia mainly at large distances from vessels (category
A). The plot for the tumour with the more diffuse hypoxic pattern
(category C) is less steep with a much higher median value
(=0.26).
Relation between vasculature and hypoxia
We sought for further correlations between vascular density, rela-
tive vascular volume, and hypoxic fraction. There was a signifi-
cant correlation between relative vascular volume and vascular
density (r = 0.56, P < 0.01). There was only a weak and non-
significant inverse correlation between vascular density and
hypoxic fraction (r =  0.34, P = 0.13) (Figure 5).
In all tumours there was an increase of hypoxia with increasing
distance from the vessels. As an example, Figure 6 shows how the
arbitrary zones chosen at increasing distances from the vessels are
projected over the binary image of vessels and hypoxia in tumour
sccNij50. Figure 7 shows the relative distribution of hypoxia over
these zones for the tumours of Figure 2A–C.
DISCUSSION
Methods
With the quantitative analysis method used here we successfully
visualized and quantitated multiple parameters while maintaining
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Figure 3 Cumulative plot of hypoxic fractions of 22 tumours originating in three head and neck sitesthe tissue architecture (Rijken et al, 1995; Bussink et al, 1998,
1999). To obtain a strong signal with lower background staining
we used fluorescent labelled antibodies on frozen sections. A
disadvantage of the immunohistochemical staining is that only
specific structures are stained, i.e. the complete tissue architecture
is not visualized. Therefore we used haematoxylin-eosin staining
of consecutive sections to contour the tumour area, excluding non-
tumour tissue and areas of necrosis. Both the hypoxia and the
Vasculature and hypoxia in human head and neck cancer 679
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Figure 4 Cumulative plot of the hypoxic fractions of arbitrary subareas in three tumours (sccNij50, sccNij70, sccNij49)
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Figure 5 Vascular density versus hypoxic fraction in 22 tumours of three head and neck sitesvessel stainings gave strong signals with very low background
staining in all slides. Edge artefacts were easily recognized with
the aid of the haematoxylin-eosin stained sections and were
excluded from the analysis.
Vascular parameters
There is an abundance of literature on morphometric vascular
tumour parameters, in particular microvascular density, and their
prognostic value. For squamous cells carcinomas of the head and
neck, as for other tumour types such as carcinoma of the breast,
conflicting results have been reported. Some investigators found a
correlation between vascular density and metastatic potential
(Gasparini et al, 1993; Albo et al, 1994; Shpitzer et al, 1996;
Murray et al, 1997), whereas others did not (Leedy et al, 1994;
Dray et al, 1995; Zätterström et al, 1995; Janot et al, 1996;
Moriyama et al, 1997; Salven et al, 1997; Burian et al, 1999). In
this study no correlation was found between vascular density and
N-stage, even when the 75th percentile value or the highest value
of the subareas were used. The latter analysis was done to approx-
imate the so called ‘hot spot counting’ method which is often used
by others (Gasparini et al, 1993; Leedy et al, 1994; Shpitzer et al,
1996; Murray et al, 1997; Salven et al, 1997). Two investigators
found an association between vascular density and local tumour
control after radiation treatment (Jenssen et al, 1996; Aebersold et
al, 1999). Unfortunately, the relationship was opposite in the two
studies, one study (Jenssen et al, 1996) demonstrating increased
risk of local recurrence with low vascular density but the other
(Aebersold et al, 1999) with high vascular density. The current
study is being continued and patient numbers and follow-up will
be increased to allow meaningful correlations between the micro-
environmental parameters and treatment outcome.
Absolute values of vascular density are difficult to compare
between studies, mainly because of methodological differences, in
particular the type of endothelial marker used and the counting
technique. Our values are in the lower range compared with other
studies. This can be explained by the fact that in most studies
vessels were counted in selected, highly vascularized areas
680 KIEM Wijffels et al
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Figure 6 Binary image of vessels (red) and hypoxia (green) in tumour sccNij50 with the zones at increasing distances from the vessels superimposed(‘hotspots’), whereas in the present analysis figures are based on
the counting of an entire biopsy section. Indeed, the highest values
obtained from the arbitrary subareas correspond better with values
reported in literature. We found only a weak and non-significant
correlation between the overall vascular density and hypoxic
fraction. This indicates that a global assessment of vascularity is
probably not a good parameter for tumour oxygenation, due to the
heterogeneity in vasculature and oxygenation in tumours. Lyng et
al (1997) also demonstrated that there are large regional differ-
ences in vascularity and oxygenation in carcinomas of the uterine
cervix. At the microregional level they did however observe a
correlation between low pO2 readings by the polarographic
method (Eppendorf Histograph) and vascularity.
Hypoxia
Various methods have been described to measure tumour tissue
oxygenation including polarographic oxygen electrodes,
magnetic resonance spectroscopy, haemoglobin saturation assays,
radionuclide assays, and, as used in the present study, by immuno-
histochemical markers. Methods for assessing the radiobiological
hypoxic fraction include the classical paired survival curve assay
and, more recently, the comet assay (Olive et al, 1998). Most clin-
ical data have been obtained with the oxygen micro-electrodes.
The low water solubility of the earlier immunohistochemical
hypoxia markers prohibited their introduction in the clinic.
Pimonidazole hydrochloride however has a high water solubility
and can be easily administered intravenously in a small volume of
aqueous solution. It distributes rapidly into the tissues where
concentrations threefold of that in plasma are reached. These
properties and the absence of any significant adverse effects with
the amount required make this agent attractive for clinical use.
Raleigh et al (1999) compared pimonidazole binding with
micro-electrode measurements and with measurements of the
radiobiologically hypoxic fraction in the C3H mouse mammary
carcinoma. The oxygenation of these tumours was manipulated by
the breathing of air, hyperoxic gases, injection of hydralazine and
tumour clamping. They showed that pimonidazole binding was
well correlated with both micro-electrode measurements and the
radiobiological hypoxic fraction. A good correlation was found
between pimonidazole binding and percentage of micro-electrode
measurements ≤ 10 mmHg. This is consistent with the intracellular
binding properties of pimonidazole, rising steeply at pO2 < 10
mmHg. However, it was also clear from their data that the micro-
electrodes systematically overestimate the extent of hypoxia at 
the cellular level. Under well-oxygenated circumstances where
pimonidazole binding was almost negligible, the micro-electrodes
still recorded a significant number of readings ≤ 10 mmHg (36%).
One of the explanations given was the presence of necrosis which
produces low readings with the micro-electrodes while there is no
pimonidazole binding in these areas.
Also, when our results of hypoxic fraction assessed by
pimonidazole binding (median 0.09) are compared with studies of
micro-electrode measurements in head and neck cancer patients,
the latter report substantially higher values (Gatenby et al, 1987;
Nordsmark et al, 1996; Brizel et al, 1997). In these studies the
median of the fraction of pO2 readings <5 mmHg varied from 0.29
to 0.41. The fraction of pO2 values < 10 mmHg was generally not
reported. These measurements were mostly taken from metastatic
neck nodes in contrast to our biopsy material which originated
from the primary tumours in all cases. Central necrosis is often
observed in cross-sectional CT imaging of nodal metastasis, and
Vasculature and hypoxia in human head and neck cancer 681
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Figure 7 Relative hypoxic fractions in 50 µ m zones at increasing distance from vessels. Example of three tumours (sccNij50, sccNij70, sccNij49)682 KIEM Wijffels et al
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this may be one explanation for the discrepancy between our
results and those of the polarographic studies.
Initial studies on the clinical use of pimonidazole as a hypoxia
marker came from the group from the University of North
Carolina (Kennedy et al, 1997; Raleigh et al, 1998; Varia et al,
1998). Raleigh et al (1998) reported on 18 patients with carci-
nomas of the uterine cervix and head and neck. The area fraction
labelled with pimonidazole varied from almost zero to approxi-
mately 0.25 with a median of 0.02. Varia et al (1998) reported on
10 patients with carcinoma of the uterine cervix. Values for
pimonidazole binding were below 0.1 in 9 of the 10 patients. It is
difficult to compare the results from these two studies with the
current study because of the differences in tumour sites and the
relatively small sample sizes. Also, different methodologies were
used for assessment of the hypoxic fraction.
Another bioreductive compound of the nitroimidazole group is
‘EF5’, a pentafluorinated derivate of etanidazole. This recently
developed immunohistochemically detectable hypoxic marker has
been tested in animal tumours and xenografted human tumours
(Fenton et al, 1999). Very recently, Evans et al (2000) reported the
first clinical application of this marker.
Patterns of hypoxia
As demonstrated various patterns of hypoxia can be recognized
(Figure 2). Differences between these patterns can be quantified by
calculating the hypoxic fractions of arbitrary subareas (Figure 4)
and, maybe more interesting, by quantifying hypoxia as a function
of distance from the vessels (Figures 6 and 7). The categorization
of the tumours was based on the visual aspect of the hypoxia
staining combined with the quantitative analysis of the hypoxia
distribution over the vascular zones. The tumours shown in
Figures 1 and 2b are typical examples of the classical ‘cord-like’
tumour model described by Thomlinson and Gray (1955).
Diffusion limited hypoxia was the predominant feature of all the
tumours we analysed. However, the spatial relationship to the
vessels was not always the same. In the tumour of category A
hypoxia was virtually absent within 100 µ m of vascular structures.
Hypoxia was predominantly present at large (150 µ m   250 µ m)
distances from the vessels. In this tumour all necrotic areas could
be excluded from the analysis, i.e. Figures 2a and 6 depict only
viable tumour tissue. Thus, significant amounts of viable tumour
tissue, both hypoxic and non-hypoxic (e.g. six o’clock position in
Figure 6) were observed at large (>250 µ m) distances from blood
vessels. It can, however, not be excluded that these areas might
have had oxygen and nutritional supply from vessels above or
below the section examined. The analysis system used provides
only a two-dimensional image of the tumour which obviously is a
limitation. On the other hand, there is no good reason to assume
that the vascular architecture will be any different in the third
dimension. Since this category A tumour demonstrates large inter-
vascular distances, it is most likely that vascular structures are
sparse, also above and below the plane of the section analysed.
The category B tumour showed already some hypoxia in the first
50 µ m zone (hypoxic fraction 0.09) and a gradual increase of the
hypoxic fraction in the second and the third zones. However, at
distances > 150 µ m hypoxia seemed to decrease again. The expla-
nation for this unexpected phenomenon is a ‘contamination’ by
small areas of necrosis at these greater distances (see arrows in
Figure 2B). This was confirmed in the haematoxylin-eosin
staining. These necrotic areas were too small however to be
excluded from the analysis and because they were not labelled by
pimonidazole, in the computer calculations they were falsely
considered as ‘viable non-hypoxic tumour tissue’. Thus, in this
particular tumour, the hypoxic fractions at distances >150 µ m
were underestimated. Nevertheless, it is an interesting observation
that, while in one category of tumours (A) there are significant
amounts of viable tissue at distances >250 µ m, in other tumours
there is already necrosis at 150–200 µ m (category B). These
differences suggest that the balance between oxygen delivery and
oxygen consumption may vary among tumours of the same
histology resulting in different distributions of chronic hypoxia
and necrosis.
The tumour of category C demonstrated a considerable amount of
hypoxia within 100 µ m from the vessels with a hypoxic fraction of
0.20 at 0–50 µ m. This suggests impaired functioning of particular
vessels, either permanently or temporarily (‘acute hypoxia’). This
may also be the case, but to a lesser extent, in the category B tumour.
In xenografted tumours we demonstrated that after 10 min of expo-
sure to pimonidazole there is a weak binding in the hypoxic cells
which increases between 10 and 30 min of exposure (unpublished
data). This indicates that, with this assay, acute hypoxia probably
will only be recognized if cells are hypoxic for at least 10 min.
Together with single parameters such as vascular density and
hypoxic fraction, the pattern of hypoxic staining may give addi-
tional prognostic information and may help to select appropriate
treatment modalities. We have previously demonstrated that
carbogen can very efficiently reduce diffusion limited hypoxia in
human squamous cell carcinoma xenografts (Bussink et al, 1999).
However, preliminary data from our laboratory suggest that it is
difficult to eradicate all the hypoxia at greater distance from the
vessels. This may also be the case in the category A tumours. At
the same time there seems to be limited value in adding vasoactive
agents such as nicotinamide to the treatment of such tumours since
they exhibit no or only very little acute hypoxia. Our attempt to
categorise human tumours based on hypoxic patterns must be vali-
dated with a larger number of patients. This is the subject of
ongoing investigations.
CONCLUSION
We have presented a quantitative method for multiparameter
analysis of vascularity and hypoxia in head and neck tumours
which is clinically feasible. These measurements can be of prog-
nostic relevance. Moreover, this method yields information on
architectural patterns which may improve our understanding of the
tumour micro-environment and may in the future be of assistance
with the selection of treatment strategies.
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